# Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults

> **NCT00546585** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 126 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza A/H7N7 Vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00546585
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2013-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546585, "Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00546585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*